Element E
Advance Clinical Translatable Science by Addressing Roadblocks
Element E has the goal to advance clinical translational science (CTS) through innovative, highly-translatable research projects that address significant roadblocks in the field. Specifically, we will identify and nurture CTS projects aimed at improving dissemination and implementation of evidence-based interventions. We will leverage the resources of NJ ACTS to ensure the success of these high-impact CTS projects and disseminate findings broadly to improve clinical care and population health in New Jersey.
Project E1 - Implementation of a novel genetic services model to enhance patient care
- Recent genetic advances led to dramatic increases in genetic testing availability
- The number of patients referred for genetic services has grown faster than the number of MD clinical geneticists
- Wait times are 6-12 months for an initial appointment, which may perpetuate health disparities
Project E2 - Translating evidence on opioid overdose prevention into practice
Applying translational science to strategies and outcomes for opioid use disorder (OUD) treatment engagement among overdose survivors
- Emergency departments represent important, novel touchpoints for addressing opioid overdoses
- However, uptake of evidence-based treatment (i.e., buprenorphine) is low in emergency departments
- There are knowledge gaps on best practices for increasing treatment uptake in emergency departments
A request for proposals for the next round of Element E projects will be released in Spring 2025, with a submission deadline in fall 2025.
Element E Leadership
Emily S. Barrett, PhD
George G. Rhoads Endowed Legacy Professor of Epidemiology
Vice Chair, Department of Biostatistics and Epidemiology
Deputy Director, Rutgers Center for Environmental Exposures and Disease (CEED)
Co-Director of Population Exposures and Outcomes Research Core
Director, Maternal-Child Environmental Health Lab
esb104@eohsi.rutgers.edu
>>View Bio